# Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)

> **NCT02762851** · PHASE4 · UNKNOWN · sponsor: **McMaster University** · enrollment: 5000 (estimated)

## Conditions studied

- Heart Failure
- Influenza

## Interventions

- **OTHER:** Sterile saline
- **DRUG:** inactivated trivalent influenza vaccine

## Key facts

- **NCT ID:** NCT02762851
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2019-12
- **Final completion:** 2020-12
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2018-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762851, "Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02762851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*